Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MNPR compared with BCRX: revenue, margins and what each company keeps, and the suppliers and customers both name
MNPR
Monopar Therapeutics
Change
Mkt cap
Revenue
Revenue
BCRX
Biocryst Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
MNPR
Monopar Therapeutics
vs
BCRX
Biocryst Pharmaceuticals Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MNPR, solid
BCRX, dashed
MNPR
Monopar Therapeutics
Change
66.46
· pre 66.45
· delayed
Mkt cap
$444.9M
Revenue
—
Revenue
—
BCRX
Biocryst Pharmaceuticals Inc
Change
8.25
· pre 8.16
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$2.2B
Revenue
$218M
Q2 FY26
Revenue
$875M
FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
MNPR
Monopar Therapeutics
vs
BCRX
Biocryst Pharmaceuticals Inc
66.46
pre 66.45
delayed
Price
8.25
pre 8.16
delayed
$444.9M
Mkt cap
$2.2B
—
Revenue
$218M
Q2 FY26
—
Revenue
$875M
FY25
Change
Change
MNPR
66.46
vs
BCRX
8.25
Pre-market
Nov 3 '26
delayed